Aspen Financial Statements From 2010 to 2024
| APN Stock | 17,007 18.00 0.11% |
Check Aspen Pharmacare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspen Pharmacare's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aspen financial statements analysis is a perfect complement when working with Aspen Pharmacare Valuation or Volatility modules.
Aspen |
Aspen Pharmacare Holdings Company Current Valuation Analysis
Aspen Pharmacare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aspen Pharmacare Current Valuation | 78.78 B |
Most of Aspen Pharmacare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspen Pharmacare Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aspen Pharmacare Holdings has a Current Valuation of 78.78 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The current valuation for all South Africa stocks is significantly lower than that of the firm.
Aspen Pharmacare Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aspen Pharmacare's current stock value. Our valuation model uses many indicators to compare Aspen Pharmacare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aspen Pharmacare competition to find correlations between indicators driving Aspen Pharmacare's intrinsic value. More Info.Aspen Pharmacare Holdings is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Aspen Pharmacare Holdings is roughly 1.90 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aspen Pharmacare's earnings, one of the primary drivers of an investment's value.About Aspen Pharmacare Financial Statements
Aspen Pharmacare stakeholders use historical fundamental indicators, such as Aspen Pharmacare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aspen Pharmacare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aspen Pharmacare's assets and liabilities are reflected in the revenues and expenses on Aspen Pharmacare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aspen Pharmacare Holdings. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Aspen Stock
Aspen Pharmacare financial ratios help investors to determine whether Aspen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspen with respect to the benefits of owning Aspen Pharmacare security.